Cargando…
Transcoccygeal neurolytic ganglion impar block for perineal pain: A case series
BACKGROUND AND AIMS: Chronic perineal pain (CPP) is a poorly localized pain. Its etiology may be benign or malignant. The ganglion impar is a solitary retroperitoneal structure at sacrococcygeal junction. It provides the nociceptive and sympathetic supply to the perineal structures. CPP has been eff...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360889/ https://www.ncbi.nlm.nih.gov/pubmed/30774240 http://dx.doi.org/10.4103/joacp.JOACP_301_16 |
_version_ | 1783392600858820608 |
---|---|
author | Nalini, K. B. Shivanna, Shivakumar Vishnu, M. S. Mohan, C. V. R. |
author_facet | Nalini, K. B. Shivanna, Shivakumar Vishnu, M. S. Mohan, C. V. R. |
author_sort | Nalini, K. B. |
collection | PubMed |
description | BACKGROUND AND AIMS: Chronic perineal pain (CPP) is a poorly localized pain. Its etiology may be benign or malignant. The ganglion impar is a solitary retroperitoneal structure at sacrococcygeal junction. It provides the nociceptive and sympathetic supply to the perineal structures. CPP has been effectively managed by ganglion impar block. Here, we describe a case series of neurolytic ganglion impar block by transcoccygeal approach, analyzing its safety and efficacy. MATERIAL AND METHODS: In this study, five consecutive patients who were given ganglion impar block for CPP using a transcoccygeal approach were followed up for 2 months. The visual analog scale (VAS) score for pain at presentation, time required for the pain to reduce by 50% after the block, VAS during a 2-month follow-up, time required to perform the procedure, number of attempts, and any complications were noted. RESULTS: All the five patients had an excellent pain relief. The mean duration for decrease in VAS by 50% was 14.8 ± 3.1 min. The mean duration to perform the procedure was 10.2 ± 1.5 min. There were no complications. All the patients had clinically significant pain relief with VAS score of 2 till 2-month follow-up. CONCLUSION: Transcoccygeal ganglion impar block may offer a safe and effective treatment option for CPP as compared to opioids. This approach for neurolysis of the ganglion impar may be recommended in view of the direct course, appreciable end point, and smaller volume of neurolytic requirement. |
format | Online Article Text |
id | pubmed-6360889 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-63608892019-02-17 Transcoccygeal neurolytic ganglion impar block for perineal pain: A case series Nalini, K. B. Shivanna, Shivakumar Vishnu, M. S. Mohan, C. V. R. J Anaesthesiol Clin Pharmacol Forum Article BACKGROUND AND AIMS: Chronic perineal pain (CPP) is a poorly localized pain. Its etiology may be benign or malignant. The ganglion impar is a solitary retroperitoneal structure at sacrococcygeal junction. It provides the nociceptive and sympathetic supply to the perineal structures. CPP has been effectively managed by ganglion impar block. Here, we describe a case series of neurolytic ganglion impar block by transcoccygeal approach, analyzing its safety and efficacy. MATERIAL AND METHODS: In this study, five consecutive patients who were given ganglion impar block for CPP using a transcoccygeal approach were followed up for 2 months. The visual analog scale (VAS) score for pain at presentation, time required for the pain to reduce by 50% after the block, VAS during a 2-month follow-up, time required to perform the procedure, number of attempts, and any complications were noted. RESULTS: All the five patients had an excellent pain relief. The mean duration for decrease in VAS by 50% was 14.8 ± 3.1 min. The mean duration to perform the procedure was 10.2 ± 1.5 min. There were no complications. All the patients had clinically significant pain relief with VAS score of 2 till 2-month follow-up. CONCLUSION: Transcoccygeal ganglion impar block may offer a safe and effective treatment option for CPP as compared to opioids. This approach for neurolysis of the ganglion impar may be recommended in view of the direct course, appreciable end point, and smaller volume of neurolytic requirement. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6360889/ /pubmed/30774240 http://dx.doi.org/10.4103/joacp.JOACP_301_16 Text en Copyright: © 2019 Journal of Anaesthesiology Clinical Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Forum Article Nalini, K. B. Shivanna, Shivakumar Vishnu, M. S. Mohan, C. V. R. Transcoccygeal neurolytic ganglion impar block for perineal pain: A case series |
title | Transcoccygeal neurolytic ganglion impar block for perineal pain: A case series |
title_full | Transcoccygeal neurolytic ganglion impar block for perineal pain: A case series |
title_fullStr | Transcoccygeal neurolytic ganglion impar block for perineal pain: A case series |
title_full_unstemmed | Transcoccygeal neurolytic ganglion impar block for perineal pain: A case series |
title_short | Transcoccygeal neurolytic ganglion impar block for perineal pain: A case series |
title_sort | transcoccygeal neurolytic ganglion impar block for perineal pain: a case series |
topic | Forum Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360889/ https://www.ncbi.nlm.nih.gov/pubmed/30774240 http://dx.doi.org/10.4103/joacp.JOACP_301_16 |
work_keys_str_mv | AT nalinikb transcoccygealneurolyticganglionimparblockforperinealpainacaseseries AT shivannashivakumar transcoccygealneurolyticganglionimparblockforperinealpainacaseseries AT vishnums transcoccygealneurolyticganglionimparblockforperinealpainacaseseries AT mohancvr transcoccygealneurolyticganglionimparblockforperinealpainacaseseries |